Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wulan Li

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
BMC Cancer|April 17, 2015
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancerJianzhang Wu, Tao Wei, Qinqin Tang, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]Jiabing Wang, Lili Huang, Chanchan Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 21, 2015
A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancerLei Fan, Wulan Li, Shilong Ying, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophagesChengguang Zhao, Yuepiao Cai, Xuzhi He, et al.
Biomed Research International|February 16, 2018
Corrigendum to "Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>B"Jian Chen, Linlin Zhang, Yilai Shu, et al.
Biomed Research International|April 15, 2017
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>BJian Chen, Linlin Zhang, Yilai Shu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 27, 2014
A novel FGF2 antagonist peptide P8 with potent antiproliferation activityLei Fan, Hang Xie, Lingzi Chen, et al.
Bioorganic Chemistry|October 18, 2024
Design, green synthesis, and anti-glutamate damage screening of chalcone derivatives with spiro-heterocyclic structures as potential anti-ischemic brain and eye damage agentsJianzhang Wu, Chenyang Huang, Shuo Ren, et al.
European Journal of Medicinal Chemistry|October 5, 2024
Green synthesis of neuroprotective spirocyclic chalcone derivatives and their role in protecting against traumatic optic nerve injuryJianzhang Wu, Meiting Han, Xiangpeng Tan, et al.
European Journal of Medicinal Chemistry|September 8, 2017
Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapyPeihong Qiu, Shanshan Zhang, Yangyang Zhou, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
BMC Cancer|April 17, 2015
Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancerJianzhang Wu, Tao Wei, Qinqin Tang, et al.
Acta Pharmaceutica Sinica. B|August 15, 2022
Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350]Jiabing Wang, Lili Huang, Chanchan Chen, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 21, 2015
A peptide derivative serves as a fibroblast growth factor 2 antagonist in human gastric cancerLei Fan, Wulan Li, Shilong Ying, et al.
European Journal of Medicinal Chemistry|October 12, 2010
Synthesis and anti-inflammatory evaluation of novel mono-carbonyl analogues of curcumin in LPS-stimulated RAW 264.7 macrophagesChengguang Zhao, Yuepiao Cai, Xuzhi He, et al.
Biomed Research International|February 16, 2018
Corrigendum to "Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>B"Jian Chen, Linlin Zhang, Yilai Shu, et al.
Biomed Research International|April 15, 2017
Curcumin Analogue CA15 Exhibits Anticancer Effects on HEp-2 Cells via Targeting NF-<i>κ</i>BJian Chen, Linlin Zhang, Yilai Shu, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|July 27, 2014
A novel FGF2 antagonist peptide P8 with potent antiproliferation activityLei Fan, Hang Xie, Lingzi Chen, et al.
Bioorganic Chemistry|October 18, 2024
Design, green synthesis, and anti-glutamate damage screening of chalcone derivatives with spiro-heterocyclic structures as potential anti-ischemic brain and eye damage agentsJianzhang Wu, Chenyang Huang, Shuo Ren, et al.
European Journal of Medicinal Chemistry|October 5, 2024
Green synthesis of neuroprotective spirocyclic chalcone derivatives and their role in protecting against traumatic optic nerve injuryJianzhang Wu, Meiting Han, Xiangpeng Tan, et al.
European Journal of Medicinal Chemistry|September 8, 2017
Synthesis and evaluation of asymmetric curcuminoid analogs as potential anticancer agents that downregulate NF-κB activation and enhance the sensitivity of gastric cancer cell lines to irinotecan chemotherapyPeihong Qiu, Shanshan Zhang, Yangyang Zhou, et al.
Pageof 4